![Paul DeStefano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Paul DeStefano is Vice President of Sales for Arquest, Inc. He was National Account Executive of Arques.
Eerdere bekende functies van Paul DeStefano
Bedrijven | Functie | Einde |
---|---|---|
VaxGen, Inc.
![]() VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Directeur/Bestuurslid | 01-12-2009 |
Arquest, Inc.
![]() Arquest, Inc. Household/Personal CareConsumer Non-Durables Arquest, Inc. manufactures and supplies diapers and training pants. It offers sanitary paper products to the hospitality sectors. The company was founded in 1991 and is headquartered in Cranbury, NJ. | Verkoop & Marketing | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Arquest, Inc.
![]() Arquest, Inc. Household/Personal CareConsumer Non-Durables Arquest, Inc. manufactures and supplies diapers and training pants. It offers sanitary paper products to the hospitality sectors. The company was founded in 1991 and is headquartered in Cranbury, NJ. | Consumer Non-Durables |
VaxGen, Inc.
![]() VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |